PANBELA THERAPEUTICS INC (PBLA) SEC filings
PBLA SEC filings moved a median of -1.45% by the close. PBLA SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the PBLA overview →
60 measured PBLA SEC filing events.
Where these PBLA SEC filings landedvs 59 measured PBLA SEC filing reactions
| Middle 50% of PBLA SEC filing reactions | -9.15% to +2.31% |
|---|---|
| Median reaction (to close) | -1.45% |
| Measured reactions | 59 |
Point-in-time · zero look-ahead
Half of the 59 PBLA SEC filing events with a measured close landed between -9.15% and +2.31%; 34% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form SEC STAFF ACTION Panbela Therapeutics, | SEC filing · Form SEC | — | — | |
| Form 8-K Panbela Therapeutics, For: Feb 12 | SEC filing · Form 8-K | +0.00% | +0.09% | |
| Form 8-K Panbela Therapeutics, For: Jan 29 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K Panbela Therapeutics, For: Jan 20 | SEC filing · Form 8-K | +0.00% | -1.19% | |
| Form S-8 Panbela Therapeutics, | SEC filing · Form S-8 | +0.00% | +1.39% | |
| Form 8-K Panbela Therapeutics, For: Nov 15 | SEC filing · Form 8-K | +0.00% | +0.03% | |
| Form 10-Q Panbela Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +8.42% | |
| Form 8-K Panbela Therapeutics, For: Nov 14 | SEC filing · Form 8-K | +0.00% | +8.42% | |
| Form 8-K Panbela Therapeutics, For: Oct 22 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K Panbela Therapeutics, For: Sep 23 | SEC filing · Form 8-K | +0.00% | +0.85% | |
| Form S-1/A Panbela Therapeutics, | SEC filing · Form S-1 | +0.00% | +19.62% | |
| Form 10-Q Panbela Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Form 8-K Panbela Therapeutics, For: Aug 13 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K Panbela Therapeutics, For: Jul 24 | SEC filing · Form 8-K | -8.99% | -9.02% | |
| Form 8-K Panbela Therapeutics, For: Jun 28 | SEC filing · Form 8-K | +13.49% | +4.23% | |
| Form 8-K Panbela Therapeutics, For: May 28 | SEC filing · Form 8-K | +0.00% | -9.49% | |
| Form 10-Q Panbela Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -18.37% | -2.04% | |
| Form 8-K Panbela Therapeutics, For: May 15 | SEC filing · Form 8-K | -18.37% | -2.04% | |
| Form DEFR14A Panbela Therapeutics, | SEC filing · Form DEFR14A | +0.00% | -2.31% | |
| Form PRER14A Panbela Therapeutics, | SEC filing · Form PRER14A | +0.00% | +8.81% | |
| Form 8-K Panbela Therapeutics, For: Apr 23 | SEC filing · Form 8-K | +22.86% | +17.14% | |
| Form DEFA14A Panbela Therapeutics, | SEC filing · Form DEFA14A | +22.86% | +17.14% | |
| Form 8-K Panbela Therapeutics, For: Apr 22 | SEC filing · Form 8-K | +0.00% | +18.70% | |
| Form S-1 Panbela Therapeutics, | SEC filing · Form S-1 | -0.02% | -8.46% | |
| Form 8-K Panbela Therapeutics, For: Apr 16 | SEC filing · Form 8-K | +0.00% | -1.45% | |
| Form EFFECT Panbela Therapeutics, | SEC filing · Form EFFECT | +0.00% | -1.45% | |
| Form DEF 14A Panbela Therapeutics, For: May 03 | SEC filing · Form DEF | -0.02% | -0.81% | |
| Form EFFECT Panbela Therapeutics, | SEC filing · Form EFFECT | -3.18% | +4.38% | |
| Form POS AM Panbela Therapeutics, | SEC filing · Form POS | +0.00% | -15.38% | |
| Form S-1 Panbela Therapeutics, | SEC filing · Form S-1 | +0.00% | -15.38% | |
| Form 10-K Panbela Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -5.15% | -0.77% | |
| Form 8-K Panbela Therapeutics, For: Mar 26 | SEC filing · Form 8-K | -5.15% | -0.77% | |
| Form PRE 14A Panbela Therapeutics, For: Mar 25 | SEC filing · Form PRE | +0.00% | +3.23% | |
| Form 8-K Panbela Therapeutics, For: Mar 05 | SEC filing · Form 8-K | +37.12% | +4.53% | |
| Form 8-K Panbela Therapeutics, For: Feb 15 | SEC filing · Form 8-K | -5.71% | -9.29% | |
| Form 8-K Panbela Therapeutics, For: Feb 07 | SEC filing · Form 8-K | +1.57% | +20.35% | |
| Form 8-K Panbela Therapeutics, For: Feb 01 | SEC filing · Form 8-K | -2.88% | -9.35% | |
| Form 8-K Panbela Therapeutics, For: Jan 28 | SEC filing · Form 8-K | -1.97% | -2.63% | |
| Form EFFECT Panbela Therapeutics, | SEC filing · Form EFFECT | -1.97% | -2.63% | |
| Form 8-K Panbela Therapeutics, For: Jan 22 | SEC filing · Form 8-K | -2.41% | -13.10% | |
| Form S-1/A Panbela Therapeutics, | SEC filing · Form S-1 | -2.41% | -13.10% | |
| Form S-1/A Panbela Therapeutics, | SEC filing · Form S-1 | +4.02% | -35.32% | |
| Form 8-K Panbela Therapeutics, For: Jan 18 | SEC filing · Form 8-K | +4.02% | -35.32% | |
| Form D Panbela Therapeutics, | SEC filing · Form D | — | -6.97% | |
| Form S-8 Panbela Therapeutics, | SEC filing · Form S-8 | -4.24% | -1.83% | |
| Form S-1 Panbela Therapeutics, | SEC filing · Form S-1 | +0.41% | -6.06% | |
| Form 8-K Panbela Therapeutics, For: Dec 19 | SEC filing · Form 8-K | -4.93% | -12.22% | |
| Form 8-K Panbela Therapeutics, For: Dec 21 | SEC filing · Form 8-K | -4.93% | -12.22% | |
| Form DEFA14A Panbela Therapeutics, | SEC filing · Form DEFA14A | -4.93% | -12.22% | |
| Form EFFECT Panbela Therapeutics, | SEC filing · Form EFFECT | -4.93% | -12.22% | |
| Form 8-K Panbela Therapeutics, For: Nov 28 | SEC filing · Form 8-K | -2.61% | -9.72% | |
| Form DEFA14A Panbela Therapeutics, | SEC filing · Form DEFA14A | -2.61% | -9.72% | |
| Form DEF 14A Panbela Therapeutics, For: Dec 19 | SEC filing · Form DEF | -0.28% | -6.06% | |
| Form S-1 Panbela Therapeutics, | SEC filing · Form S-1 | +1.51% | +3.43% | |
| Form D Panbela Therapeutics, | SEC filing · Form D | -1.34% | -8.03% | |
| Form PRE 14A Panbela Therapeutics, For: Nov 14 | SEC filing · Form PRE | -0.03% | +0.50% | |
| Form 10-Q Panbela Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -1.61% | -3.63% | |
| Form 8-K Panbela Therapeutics, For: Nov 09 | SEC filing · Form 8-K | -1.61% | -3.63% | |
| Form 8-K Panbela Therapeutics, For: Nov 02 | SEC filing · Form 8-K | +1.82% | +7.09% | |
| Form DEFA14A Panbela Therapeutics, | SEC filing · Form DEFA14A | +1.82% | +7.09% |
Keep exploring
More PBLA: earnings → · analyst actions → · PBLA overview →